Morgan Stanley’s Montes Archimedes Acquisition Corp. Class A Common Stock MAAC Stock Holding History

Morgan Stanley’s Portfolio MAAC Stock Details MAAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-541	Closed	-$5K	–	8454
2021 Q3	$5K	Buy	541 +434	+406%	+$4.31K	﹤0.01%	7522
2021 Q2	$1K	Sell	107 -2,798	-96%	-$27.6K	﹤0.01%	7719
2021 Q1	$28K	Buy	+2,905	New	+$29.5K	﹤0.01%	6604

Morgan Stanley's MAAC Position: Q4 2021 in Review

Morgan Stanley sold out of Montes Archimedes Acquisition Corp. Class A Common Stock (MAAC) in Q4 2021, closing a stake of 541 shares — an estimated $5K sold.

Morgan Stanley first reported a position in MAAC in Q1 2021 and held it in 3 quarters. The position peaked at $28K in Q1 2021. 0 funds tracked by Wall St. Rank hold MAAC as of Q4 2021.

Morgan Stanley reported no remaining Montes Archimedes Acquisition Corp. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
Morgan Stanley sold 541 Montes Archimedes Acquisition Corp. Class A Common Stock shares in Q4 2021, an estimated $5K.
Morgan Stanley first reported a position in Montes Archimedes Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 3 quarters.
Morgan Stanley's Montes Archimedes Acquisition Corp. Class A Common Stock position peaked at $28K in Q1 2021.
0 funds tracked by Wall St. Rank held Montes Archimedes Acquisition Corp. Class A Common Stock as of Q4 2021.

Based on Morgan Stanley's 13F filing for Q4 2021, filed 14 Feb 2022.